HARROW INC (HROW)
US4158581094 - Common Stock
Harrow to Present at Two Investor Conferences in May
Keep an eye on the top gainers and losers in Tuesday's session, as they reflect the most notable price movements.
Which stocks are experiencing notable movement on Tuesday?
Tuesday's session: gap up and gap down stocks
Let's delve into the US markets on Tuesday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.
HROW Stock Earnings: Harrow Health Misses EPS, Misses Revenue for Q1 2024
HROW stock results show that Harrow Health missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
HROW Stock Earnings: Harrow Health Misses EPS, Misses Revenue for Q1 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Harrow Health (NASDAQ:HROW) just reported results for the first quarter of 2024...
Which stocks are moving after the closing bell on Monday?
As the regular session of the US market on Monday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.
Harrow Announces First Quarter 2024 Financial Results
Harrow Names Greg DiPasquale as Senior Vice President, Head of Commercial
Notable Friday Option Activity: WRBY, HD, HROW
Harrow Will Release First Quarter 2024 Financial Results After Market Close on May 13, 2024
Top Buys by Directors: Baum's $165.1K Bet on HROW
Melt Pharmaceuticals Closes $24 Million Series B Preferred Stock Financing
Tuesday 3/26 Insider Buying Report: HROW, LEGH
Noteworthy Wednesday Option Activity: HROW, SAFE, NKTX
INTC Stock Alert: Intel Just Got a Major $8.5 Billion Boost
Intel stock is rising on Wednesday as investors in INTC shares react to the semiconductor company securing $8.5 billion in funding.
Why Is Aquestive Therapeutics (AQST) Stock Down 14% Today?
Aquestive Therapeutics stock is falling on Wednesday after the company price a public offering for AQST shares this morning.
Why Is Harrow (HROW) Stock Up 5% Today?
Harrow stock is up on Wednesday as investors in HROW shares react to the company's earnings report for the fourth quarter of 2023!
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Pre-market stock movers are worth checking out as we dive into all of the biggest movements worth reading about on Wednesday morning!
HROW Stock Earnings: Harrow Health Misses EPS, Misses Revenue for Q4 2023
HROW stock results show that Harrow Health missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.
HROW Stock Earnings: Harrow Health Misses EPS, Misses Revenue for Q4 2023
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Harrow Health (NASDAQ:HROW) just reported results for the fourth quarter of 202...
Harrow Announces Fourth Quarter and Year-End 2023 Financial Results
Harrow Will Release Fourth Quarter and Year-End 2023 Financial Results After Market Close on March 19, 2024
Harrow Licenses Canadian Rights to Apotex for Five Branded Ophthalmic Pharmaceutical Products
Harrow Announces New Appointments to its Board of Directors
Commit To Buy Harrow At $8, Earn 20.1% Annualized Using Options
Harrow says dry eye drug Vevye now available in US (NASDAQ:HROW)
Harrow (HROW) said that its licensed medication Vevye is now available in the US for the treatment of the signs and symptoms of dry eye disease. Read more here.
